- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
迄今为止，共4家主力机构，持仓量总计2.08亿股，占流通A股51.51%
- 波段诊断：
-
技术面诊股
诊断结果：7.1技术面打败了30%的股票
技术面评分前10的股票
近期的平均成本为5.53元，股价在成本上方运行。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为5.53元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.53","date":1594612227,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2020.07.13","stock":"3.53","trade":"4.15","ind":"3.50"},{"date":"2020.07.10","stock":"-1.10","trade":"1.79","ind":"-0.61"},{"date":"2020.07.09","stock":"2.64","trade":"4.16","ind":"2.60"},{"date":"2020.07.08","stock":"0.76","trade":"1.14","ind":"1.84"},{"date":"2020.07.07","stock":"0.76","trade":"1.91","ind":"1.72"},{"date":"2020.07.06","stock":"2.55","trade":"1.59","ind":"4.09"},{"date":"2020.07.03","stock":"0.99","trade":"1.06","ind":"1.33"},{"date":"2020.07.02","stock":"0.20","trade":"0.20","ind":"1.29"},{"date":"2020.07.01","stock":"-1.37","trade":"-0.26","ind":"1.01"},{"date":"2020.06.30","stock":"0.59","trade":"1.26","ind":"2.04"},{"date":"2020.06.29","stock":"0.40","trade":"1.65","ind":"-0.52"},{"date":"2020.06.24","stock":"-0.59","trade":"-0.62","ind":"0.17"},{"date":"2020.06.23","stock":"-0.97","trade":"1.03","ind":"0.78"},{"date":"2020.06.22","stock":"-1.72","trade":"0.31","ind":"0.29"},{"date":"2020.06.19","stock":"-0.38","trade":"0.70","ind":"1.51"},{"date":"2020.06.18","stock":"-2.42","trade":"-2.21","ind":"0.65"},{"date":"2020.06.17","stock":"2.09","trade":"3.02","ind":"0.19"},{"date":"2020.06.16","stock":"-0.19","trade":"2.16","ind":"1.85"},{"date":"2020.06.15","stock":"2.52","trade":"2.71","ind":"-0.53"},{"date":"2020.06.12","stock":"0.00","trade":"1.49","ind":"0.07"},{"date":"2020.06.11","stock":"-0.39","trade":"-0.52","ind":"-0.81"}]
双成药业,深证成指,生物制品指数
压力支撑
该股压力位为5.47元，支撑位为5.35元。
[{"text":"\u538b\u529b\u4f4d","value":"5.47","date":1594569600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.35","date":1594569600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.3资金面打败了46%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流入较多，投资者可加强关注该行业的个股。
更新时间：07月14日 12:30
| 机构今日流向(万元) | 6237.66 | 机构5日流向(万元) | 14109.50 |
| 机构10日流向(万元) | -1692.78 | 机构20日流向(万元) | 3696.16 |
机构持仓
2020-03-31 与 2019-12-31 相比，主力机构持仓量增加148.37万股，其中基金数没有增加，主力净减仓3家，暂未发现中长期投资价值。
截止2020-03-31，共4家主力机构（一般法人4家），持仓量总计20778.98万股，占流通A股51.51%
其中，基金持仓与2019-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有183.9万股
从主力名单中消失：4家 ，原持有35.53万股
其中，基金持仓与2019-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有183.9万股
从主力名单中消失：4家 ，原持有35.53万股
消息面诊股
诊断结果：5.7消息面打败了28%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 双成药业10:30大单揭秘:主动大单卖出5738手
2020-07-14 - 双成药业10:30大单揭秘:主动大单买入2376手
2020-07-10 - 双成药业10:30大单揭秘:主动大单买入3565手
2020-07-09 - 双成药业已上市多肽药物竞争激烈 主业持续亏损待解
2020-07-08 - 双成药业10:30大单揭秘:主动大单卖出6414手
2020-07-08 - 双成药业14:30大单揭秘:主动大单买入5024手
2020-07-03 - 双成药业14:30大单揭秘:主动大单卖出8499手
2020-07-02 - 双成药业14:30大单揭秘:主动大单卖出4501手
2020-07-01 - 双成药业10:30大单揭秘:主动大单卖出2450手
2020-07-01 - 双成药业主业持续亏损遭深交所问询 销售费用增加但营
2020-06-30
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2020-06-09 |
| 一般消息 | 募资投向 | 公司购买资产 | 2020-06-09 |
| 一般消息 | 重大事项 | 关联交易 | 2020-06-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2020-04-29 |
| 利好 | 业绩预告 | 预计减亏 | 2020-04-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-04-07 |
| 一般消息 | 募资投向 | 公司出售资产 | 2020-03-31 |
| 利好 | 业绩预告 | 预计扭亏 | 2020-01-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2020-01-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2019-08-16 |
| 一般消息 | 重大事项 | 关联交易 | 2019-07-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.5行业面打败了72%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2020.07.13","price":"3.50","value":"4.15"},{"date":"2020.07.10","price":"-0.61","value":"1.79"},{"date":"2020.07.09","price":"2.60","value":"4.16"},{"date":"2020.07.08","price":"1.84","value":"1.14"},{"date":"2020.07.07","price":"1.72","value":"1.91"},{"date":"2020.07.06","price":"4.09","value":"1.59"},{"date":"2020.07.03","price":"1.33","value":"1.06"},{"date":"2020.07.02","price":"1.29","value":"0.20"},{"date":"2020.07.01","price":"1.01","value":"-0.26"},{"date":"2020.06.30","price":"2.04","value":"1.26"},{"date":"2020.06.29","price":"-0.52","value":"1.65"},{"date":"2020.06.24","price":"0.17","value":"-0.62"},{"date":"2020.06.23","price":"0.78","value":"1.03"},{"date":"2020.06.22","price":"0.29","value":"0.31"},{"date":"2020.06.19","price":"1.51","value":"0.70"},{"date":"2020.06.18","price":"0.65","value":"-2.21"},{"date":"2020.06.17","price":"0.19","value":"3.02"},{"date":"2020.06.16","price":"1.85","value":"2.16"},{"date":"2020.06.15","price":"-0.53","value":"2.71"},{"date":"2020.06.12","price":"0.07","value":"1.49"},{"date":"2020.06.11","price":"-0.81","value":"-0.52"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 辽宁成大 | 56.94% | 25.58% | 6.8分 |
| 2 | 中源协和 | 51.90% | 20.63% | 5.6分 |
| 3 | 特宝生物 | 49.04% | -0.40% | 5.3分 |
| 4 | 博雅生物 | 46.05% | 5.61% | 6.6分 |
| 5 | 安科生物 | 40.46% | 19.31% | 6.5分 |
| 6 | ST生物 | 39.24% | 1.02% | 5.8分 |
| 8 | 康泰生物 | 38.09% | 25.36% | 6.7分 |
| 10 | 华兰生物 | 31.45% | 15.30% | 6.3分 |
| 12 | 上海莱士 | 28.04% | 18.75% | 6.4分 |
| 14 | 溢多利 | 27.48% | 10.22% | 6.1分 |
| 16 | ST金花 | 25.06% | 6.74% | 5.6分 |
| 18 | 常山药业 | 24.68% | 9.29% | 6.4分 |
| 20 | 双鹭药业 | 22.66% | 6.34% | 5.8分 |
| 22 | 赛升药业 | 21.56% | 12.03% | 4.9分 |
| 24 | 莱茵生物 | 19.36% | 8.43% | 5.8分 |
| 26 | 天坛生物 | 16.74% | 12.21% | 6.8分 |
| 28 | 通化东宝 | 15.81% | 4.18% | 6.4分 |
| 30 | 钱江生化 | 14.20% | 10.04% | 5.8分 |
| 32 | 万泽股份 | 13.33% | 6.94% | 6.7分 |
| 34 | *ST交昂 | 9.57% | 6.19% | 5.7分 |
| 36 | 我武生物 | 4.72% | 8.92% | 6.3分 |
| 38 | 甘李药业 | - | 61.06% | 6.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2020-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 35/105 ， 20/105。
[{"date":"2020-03-31","value":"-0.97","vol":"1.12"},{"date":"2019-12-31","value":"4.62","vol":"-254.30"},{"date":"2019-09-30","value":"-4.23","vol":"-12.23"},{"date":"2019-06-30","value":"-2.83","vol":"-3.80"},{"date":"2019-03-31","value":"-1.72","vol":"-0.61"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.97 | 4.62 | -4.23 | -2.83 | -1.72 |
| 行业(%) | 1.12 | -254.30 | -12.23 | -3.80 | -0.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"77.51","vol":"64.51"},{"date":"2019-12-31","value":"72.56","vol":"66.95"},{"date":"2019-09-30","value":"70.82","vol":"66.15"},{"date":"2019-06-30","value":"70.13","vol":"-561.64"},{"date":"2019-03-31","value":"64.30","vol":"65.74"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
77.51 | 72.56 | 70.82 | 70.13 | 64.30 |
| 行业(%) | 64.51 | 66.95 | 66.15 | -561.64 | 65.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 32/105 ， 10/105。
[{"date":"2020-03-31","value":"-32.37","vol":"-6.87"},{"date":"2019-12-31","value":"2.79","vol":"641.29"},{"date":"2019-09-30","value":"4.15","vol":"708.95"},{"date":"2019-06-30","value":"0.60","vol":"398.32"},{"date":"2019-03-31","value":"-17.68","vol":"139.10"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-32.37 | 2.79 | 4.15 | 0.60 | -17.68 |
| 行业(%) | -6.87 | 641.29 | 708.95 | 398.32 | 139.10 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"40.78","vol":"80.49"},{"date":"2019-12-31","value":"135.50","vol":"36.54"},{"date":"2019-09-30","value":"33.34","vol":"251.87"},{"date":"2019-06-30","value":"22.58","vol":"-9.07"},{"date":"2019-03-31","value":"-157.87","vol":"-8.71"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
40.78 | 135.50 | 33.34 | 22.58 | -157.87 |
| 行业(%) | 80.49 | 36.54 | 251.87 | -9.07 | -8.71 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 24/105 ， 19/105。
[{"date":"2020-03-31","value":"0.06","vol":"0.08"},{"date":"2019-12-31","value":"0.33","vol":"0.44"},{"date":"2019-09-30","value":"0.26","vol":"0.31"},{"date":"2019-06-30","value":"0.17","vol":"0.20"},{"date":"2019-03-31","value":"0.07","vol":"0.08"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.33 | 0.26 | 0.17 | 0.07 |
| 行业(次) | 0.08 | 0.44 | 0.31 | 0.20 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.24","vol":"0.29"},{"date":"2019-12-31","value":"1.42","vol":"1.66"},{"date":"2019-09-30","value":"1.23","vol":"1.22"},{"date":"2019-06-30","value":"0.76","vol":"0.83"},{"date":"2019-03-31","value":"0.36","vol":"0.33"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.24 | 1.42 | 1.23 | 0.76 | 0.36 |
| 行业(次) | 0.29 | 1.66 | 1.22 | 0.83 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-03-31","value":"-57.29","vol":"-2633.34"},{"date":"2019-12-31","value":"35.37","vol":"-5405.31"},{"date":"2019-09-30","value":"20.95","vol":"-796.16"},{"date":"2019-06-30","value":"2.40","vol":"-382.50"},{"date":"2019-03-31","value":"22.53","vol":"-204.03"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -57.29 | 35.37 | 20.95 | 2.40 | 22.53 |
| 行业 | -2633.34 | -5405.31 | -796.16 | -382.50 | -204.03 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"","vol":"0.27"},{"date":"2019-12-31","value":"0.85","vol":"3.19"},{"date":"2019-09-30","value":"","vol":"0.48"},{"date":"2019-06-30","value":"0.35","vol":"3.31"},{"date":"2019-03-31","value":"","vol":"1.05"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.85 | - | 0.35 | - |
| 行业 | 0.27 | 3.19 | 0.48 | 3.31 | 1.05 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/105 ， 19/105。
[{"date":"2020-03-31","value":"2.14","vol":"5.42"},{"date":"2019-12-31","value":"2.41","vol":"4.69"},{"date":"2019-09-30","value":"1.81","vol":"4.82"},{"date":"2019-06-30","value":"2.17","vol":"4.53"},{"date":"2019-03-31","value":"2.36","vol":"4.30"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.14 | 2.41 | 1.81 | 2.17 | 2.36 |
| 行业 | 5.42 | 4.69 | 4.82 | 4.53 | 4.30 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"1.66","vol":"4.11"},{"date":"2019-12-31","value":"1.89","vol":"3.48"},{"date":"2019-09-30","value":"1.42","vol":"3.01"},{"date":"2019-06-30","value":"1.61","vol":"2.97"},{"date":"2019-03-31","value":"1.60","vol":"2.78"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.66 | 1.89 | 1.42 | 1.61 | 1.60 |
| 行业 | 4.11 | 3.48 | 3.01 | 2.97 | 2.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 13/105 ， 9/105。
[{"date":"2020-03-31","value":"30.50","vol":"25.94"},{"date":"2019-12-31","value":"28.68","vol":"26.47"},{"date":"2019-09-30","value":"32.11","vol":"27.29"},{"date":"2019-06-30","value":"32.48","vol":"27.38"},{"date":"2019-03-31","value":"33.33","vol":"24.62"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.50 | 28.68 | 32.11 | 32.48 | 33.33 |
| 行业(%) | 25.94 | 26.47 | 27.29 | 27.38 | 24.62 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.54","vol":"0.53"},{"date":"2019-12-31","value":"0.50","vol":"1.07"},{"date":"2019-09-30","value":"0.60","vol":"0.46"},{"date":"2019-06-30","value":"0.61","vol":"0.43"},{"date":"2019-03-31","value":"0.64","vol":"0.40"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.54 | 0.50 | 0.60 | 0.61 | 0.64 |
| 行业(%) | 0.53 | 1.07 | 0.46 | 0.43 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2020年的收益，请投资者后续关注。
[{"date":"2016","yellowRectValue":"-3.88","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"0.06","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"-0.69","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]